Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · IEX Real-Time Price · USD
1.990
-0.100 (-4.78%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Lexicon Pharmaceuticals Revenue
Lexicon Pharmaceuticals had revenue of $2.31M in the twelve months ending March 31, 2024, with 1,734.13% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.13M with 4,608.33% year-over-year growth. In the year 2023, Lexicon Pharmaceuticals had annual revenue of $1.20M with 766.19% growth.
Revenue (ttm)
$2.31M
Revenue Growth
+1,734.13%
P/S Ratio
311.28
Revenue / Employee
$8,109
Employees
285
Market Cap
719.37M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.20M | 1.07M | 766.19% |
Dec 31, 2022 | 139.00K | -159.00K | -53.36% |
Dec 31, 2021 | 298.00K | -23.70M | -98.76% |
Dec 31, 2020 | 24.00M | -298.08M | -92.55% |
Dec 31, 2019 | 322.07M | 258.86M | 409.54% |
Dec 31, 2018 | 63.21M | -28.48M | -31.06% |
Dec 31, 2017 | 91.69M | 12.43M | 15.69% |
Dec 31, 2016 | 79.26M | -50.76M | -39.04% |
Dec 31, 2015 | 130.01M | 107.16M | 468.89% |
Dec 31, 2014 | 22.85M | 20.63M | 928.53% |
Dec 31, 2013 | 2.22M | 1.13M | 104.04% |
Dec 31, 2012 | 1.09M | -760.00K | -41.10% |
Dec 31, 2011 | 1.85M | -3.06M | -62.33% |
Dec 31, 2010 | 4.91M | -5.79M | -54.13% |
Dec 31, 2009 | 10.70M | -21.62M | -66.89% |
Dec 31, 2008 | 32.32M | -17.80M | -35.51% |
Dec 31, 2007 | 50.12M | -22.68M | -31.15% |
Dec 31, 2006 | 72.80M | -2.88M | -3.81% |
Dec 31, 2005 | 75.68M | 13.94M | 22.58% |
Dec 31, 2004 | 61.74M | 18.90M | 44.12% |
Dec 31, 2003 | 42.84M | 7.64M | 21.70% |
Dec 31, 2002 | 35.20M | 4.62M | 15.12% |
Dec 31, 2001 | 30.58M | 16.12M | 111.47% |
Dec 31, 2000 | 14.46M | 9.72M | 205.17% |
Dec 31, 1999 | 4.74M | 2.50M | 111.34% |
Dec 31, 1998 | 2.24M | 1.27M | 131.66% |
Dec 31, 1997 | 967.74K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Weave Communications | 178.08M |
Wave Life Sciences | 112.91M |
Sage Therapeutics | 91.06M |
4D Molecular Therapeutics | 20.45M |
Arbutus Biopharma | 12.99M |
Stoke Therapeutics | 7.85M |
LXRX News
- 13 days ago - Lexicon Board of Directors Appoints Mike Exton, Ph.D. as New Chief Executive Officer and Director - GlobeNewsWire
- 4 weeks ago - Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes - GlobeNewsWire
- 4 weeks ago - Data From Lexicon's RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association - GlobeNewsWire
- 5 weeks ago - Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored Presentations at the 84th Scientific Sessions of the American Diabetes Association - GlobeNewsWire
- 7 weeks ago - Lexicon Pharmaceuticals Selects Medidata to Help Advance First Non-Opioid Drug for Neuropathic Pain in Over Two Decades - Business Wire
- 7 weeks ago - Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2024 - GlobeNewsWire
- 2 months ago - New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction - GlobeNewsWire
- 2 months ago - Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024 - GlobeNewsWire